78 results
8-K
EX-99.1
BTAX
Biostax Corp.
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
platform for stakeholders, partners, and the public to access relevant information about its initiatives and progress.
About Biostax
Biostax
8-K
EX-10.1
BTAX
Biostax Corp.
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
Licensor or a licensee of the Licensor with the right to reference, cross-reference, review, have access to, incorporate and use all documents and other … demonstrated by the receiving party to have been independently developed by the receiving party without access to the disclosing party’s Confidential
8-K
BTAX
Biostax Corp.
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
the right to reference, review, have access to or use documents filed by or on behalf of the Company and any of its affiliates upon a termination
8-K
EX-10.1
q435yj8fdka18eg6r6zx
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
xlpsn2 r93
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm
8-K
1864lbtnbhkt7h
14 May 20
Other Events
10:08am